11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:58 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024
6:08 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:09 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
3:23 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:07 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:05 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/01/2024
4:02 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:24 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:30 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:17 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:07 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:46 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
4:28 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/25/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:44 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:51 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
11:37 AM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
10/24/2024
4:53 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
4:04 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
3:15 PM | Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
4:59 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:38 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:39 PM | Janux Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
10/23/2024
4:07 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:36 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:20 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:16 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/22/2024
3:17 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
10/21/2024
3:43 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:25 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
12:39 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
5:51 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:39 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:48 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:06 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:24 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:18 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
5:14 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad) If you missed out on Nvidia, watch this video I just made. Click here for full details. |
10/16/2024
4:35 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:28 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:25 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:17 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:10 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
7:49 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:29 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:34 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:31 PM | DiRaimondo Thomas (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:32 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
5:31 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
4:05 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:51 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:51 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:54 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:18 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:01 PM | Janux Therapeutics (Subject)
Meyer Andrew Hollman (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:05 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:35 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:13 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
8:35 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/16/2024
8:41 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:01 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
8:18 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
7:54 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
8:07 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
7:42 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:23 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:51 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/11/2024
10:20 AM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/10/2024
5:26 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:32 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:22 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:51 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:02 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:13 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:03 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:09 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
2:35 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/09/2024
1:28 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
6:11 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
6:14 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
6:17 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
6:06 PM | Dobek Maria (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
3:20 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:28 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
7:00 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 4/A | |
07/24/2024
7:00 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 4/A | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
07/22/2024
7:01 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
7:01 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
7:03 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
7:04 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
4:00 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
3:30 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:30 PM | Janux Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:30 PM | Barrett Ronald W (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:30 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free JANX Stock Alerts